Home › Funds › MMCAP International Inc. SPC › CRDL

MMCAP International Inc. SPC position in CRDL

CARDIOL THERAPEUTICS INC · Health Care

MMCAP International Inc. SPC reported holding 15,598,560 shares of CRDL (CARDIOL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$25.9M, representing 1.84% of its reported portfolio and ranking #5 among its reported holdings. MMCAP International Inc. SPC has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.60M sh
Reported value held$25.89M
Portfolio Weight1.84%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MMCAP International Inc. SPC's CRDL position evolved

MMCAP International Inc. SPC first disclosed a stake in CRDL in Q3 2023 at 2,953,300 shares (US$2.64B). The position peaked in Q1 2024 at 2,566,125 shares, worth US$4.64B. Across 13 filings, MMCAP International Inc. SPC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 15,598,560 shares valued at US$25.9M. Notable position changes include a 64% trim in Q2 2024 (shares fell 2% over the following quarter), a 63% trim in Q2 2025 (shares fell 21% over the following quarter), a 7247% increase in Q1 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.95M $2.64B New
Q4 2023 2.95M $2.66B Hold
Q1 2024 2.57M $4.64B Reduce
Q2 2024 924.12K $1.87B Reduce
Q3 2024 795.62K $1.58B Reduce
Q4 2024 795.62K $1.02M Hold
Q1 2025 782.62K $758.99K Reduce
Q2 2025 293.06K $398.56K Reduce
Q3 2025 293.06K $313.57K Hold
Q4 2025 208.95K $199.30K Reduce
Q1 2026 15.35M $20.73M Add
Q2 2026 15.60M $16.53M Add
Q3 2026 15.60M $25.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRDL and 13F data

CRDL (CARDIOL THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CRDL — the largest reported positions include Tejara Capital Ltd (US$12.3M), AIGH Capital Management LLC (US$166K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRDL

All CRDL fund holders →

FAQ

How long has MMCAP International Inc. SPC held CRDL?

MMCAP International Inc. SPC has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MMCAP International Inc. SPC's current position in CRDL?

As of Q3 2026, MMCAP International Inc. SPC holds 15.60M shares of CRDL (CARDIOL THERAPEUTICS INC), valued at $25.89M, representing 1.84% of its reported portfolio and ranking #5.

Has MMCAP International Inc. SPC been buying or selling CRDL?

In the latest 13F filing (Q3 2026), MMCAP International Inc. SPC held unchanged its position in CRDL. The position peaked in Q1 2024 at 2.57M shares.

Which other funds hold CRDL?

Other major institutional holders of CRDL include Tejara Capital Ltd, AIGH Capital Management LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.